Pyxant Labs Competitors and Similar CompaniesClear all
Pyxant Labs's competitors and similar companies include Prometheus Biosciences, Interpace Diagnostics, Opko Health and Sysmex Inostics.
 Prometheus Biosciences Prometheus Biosciences (formerly known as Precision IBD) is a biopharmaceutical company committed to the discovery, development, and commercialization of therapeutics and diagnostics for patients with gastroenterology and autoimmune diseases. |  Interpace Diagnostics Interpace Diagnostics is a health care commercialization company providing insight-driven, integrated multi-channel message delivery for health care companies. |  Opko Health Opko Health engages in the discovery and development of novel and proprietary technologies for pharmaceuticals and diagnostics. |  Sysmex Inostics Sysmex Inostics is a molecular diagnostics company that provides testing for physicians, clinical trials, and researchers. | ||
Founding Date | Founding Date 2000 | Founding Date 1995 | Founding Date 1987 | Founding Date 2007 | Founding Date 2008 |
Type | Type Private | Type Subsidiary | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Colorado Springs, US HQ Millcreek, US | Locations San Diego, US HQ | Locations Parsippany-Troy Hills, US HQ Morrisville, US Pittsburgh, US | Locations Miami, US HQ Woburn, US | Locations Hamburg, DE HQ Kobe, JP Baltimore, US |
Employees | Employees 1221% decrease | Employees 9735% increase | Employees 8919% increase | Employees 6,0967% increase | Employees 65 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 11.5 m | Valuation ($) 1.1 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $6.8m (FY, 2022) | Revenue (est.) $38.7m (FY, 2025) | Revenue (est.) $606.9m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $14.6m (FY, 2025) | Cost of goods $400.9m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $24.1m (FY, 2025) | Gross profit $205.9m (FY, 2025) | Gross profit N/A |
Net income | Net income N/A | Net income ($141.8m) (FY, 2022) | Net income $24.6m (FY, 2025) | Net income ($225.7m) (FY, 2025) | Net income N/A |
Operating ⚠ | |||||
Patents (US) | Patents (US) N/A | Patents (US) 11 (Mar, 2021) | Patents (US) 1 (FY, 2016) | Patents (US) N/A | Patents (US) N/A |
Funding | |||||
Total funding raised | Total funding raised $ 530k | Total funding raised $ 130m | Total funding raised N/A | Total funding raised $ 31m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Prometheus Biosciences
HQ
San Diego, US
Prometheus Biosciences (formerly known as Precision IBD) is a biopharmaceutical company committed to the discovery, development, and commercialization of therapeutics and diagnostics for patients with gastroenterology and autoimmune diseases.
View companyInterpace Diagnostics
HQ
Parsippany-Troy Hills, US
Employees
89↑ 19% increase
Interpace Diagnostics is a health care commercialization company providing insight-driven, integrated multi-channel message delivery for health care companies.
View companyOpko Health
HQ
Miami, US
Employees
6,096↑ 7% increase
Opko Health engages in the discovery and development of novel and proprietary technologies for pharmaceuticals and diagnostics.
View companySysmex Inostics
HQ
Hamburg, DE
Sysmex Inostics is a molecular diagnostics company that provides testing for physicians, clinical trials, and researchers.
View company